4FEU
Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 21-ID-G |
Synchrotron site | APS |
Beamline | 21-ID-G |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2011-03-21 |
Detector | MAR scanner 300 mm plate |
Wavelength(s) | 0.97856 |
Spacegroup name | P 1 |
Unit cell lengths | 57.752, 94.161, 96.766 |
Unit cell angles | 61.21, 73.11, 87.36 |
Refinement procedure
Resolution | 19.970 - 2.370 |
R-factor | 0.1628 |
Rwork | 0.160 |
R-free | 0.21460 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | PDB 4EJ7 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.070 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHENIX |
Refinement software | BUSTER (2.8.0) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.000 | 2.410 |
High resolution limit [Å] | 2.370 | 2.370 |
Number of reflections | 67481 | |
<I/σ(I)> | 16.35 | 2 |
Completeness [%] | 98.4 | 98.4 |
Redundancy | 2.7 | 2.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 4.5 | 298 | 0.1 M sodium acetate pH 4.5, 8% PEG3350, 3% DMSO, 0.2 M NDSB221, 2 mM kanamycin, 3 mM SP600125, VAPOR DIFFUSION, SITTING DROP, temperature 298K |